Digital Health Applications for Pharmacogenetic Clinical Trials
Digital health (DH) is the use of digital technologies and data analytics to understand health-related behaviors and enhance personalized clinical care. DH is increasingly being used in clinical trials, and an important field that could potentially benefit from incorporating DH into trial design is...
Main Authors: | Hetanshi Naik, Latha Palaniappan, Euan A. Ashley, Stuart A. Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/11/1261 |
Similar Items
-
Editorial: Digital health and neuroscience: Recent history, current trends, and future developments
by: Miguel Pais-Vieira, et al.
Published: (2022-11-01) -
Acenocoumarol Pharmacogenetic Dosing Algorithm versus Usual Care in Patients with Venous Thromboembolism: A Randomised Clinical Trial
by: Hoi Yan Tong, et al.
Published: (2021-06-01) -
Changes in the digital health landscape in cardiac electrophysiology: A pre-and peri-pandemic COVID-19 era survey
by: Janet K. Han, MD, FHRS, et al.
Published: (2021-02-01) -
Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
by: Nita A Limdi, et al.
Published: (2012-10-01) -
Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial
by: Víctor Pérez, et al.
Published: (2017-07-01)